Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


December 5-6, 2017
Renaissance Washington DC Downtown,
Washington, D.C.

Marshal in the Next Era of US Regulatory Policy as it Intersects with Breakthrough Scientific Innovation

Connect with Federal Agencies for Regulatory Updates, Policies and Initiatives Impacting BioPharma

Discuss Current Trends & Developments with Industry Stakeholders and Hear What’s in the Pipeline for the Year Ahead

Get latest information on CDER, biosimilars, and PROs directly from decision-makers

Know What's Coming Down the Pipeline

Hear directly from CDER on goals, trends, and new drug development for 2017 and beyond.

Biosimilars Implication

Understand the economics and impacts of biosimilars on healthcare through global case studies.

The Evolving Role of PROs

Understand the implication of a more vocal patient role in drug development and feedback through a panel of patient advocacy groups and industry and FDA leaders.

Media Partners

Sponsor the 2017 Event